Does Dr. MICHELLE BARNES have financial conflicts of interest?

Dr. MICHELLE BARNES (CPNP) has received a total of $615 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $615 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MICHELLE BARNES?

According to CMS Open Payments data, Dr. MICHELLE BARNES received funding from SUPERNUS PHARMACEUTICALS ($282), MERCK SHARP & DOHME ($141), and AYTU BIOPHARMA ($36).

Does Dr. MICHELLE BARNES receive research grants or speaking fees?

Dr. MICHELLE BARNES has received $615 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MICHELLE BARNES

CPNPReal-Time Hydrated

Specialty: Nurse Practitioner, Pediatrics

Practice Location: ALEXANDRIA, VA 22307

NPI Number: 1124790449

LIFETIME INDUSTRY VALUE

$615

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. BARNES is a verified Nurse Practitioner, Pediatrics practitioner based in ALEXANDRIA, VA.

Between 2021 and 2024, Dr. BARNES had an overall industry promotional and research financial footprint of $615 as recorded in the federal CMS Open Payments database.

$615 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BARNES's primary funding source is SUPERNUS PHARMACEUTICALS, which accounts for $282 (representing 45.9% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SUPERNUS PHARMACEUTICALS

Rank 1

$282

45.9%

MERCK SHARP & DOHME

Rank 2

$141

23%

AYTU BIOPHARMA

Rank 3

$36

5.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.